AgraFlora Organics begins R&D trials at Winnipeg edibles manufacturing facility

AgraFlora Organics International Inc (CSE:AGRA) (OCTMKTS:AGFAF) said it has received a necessary CRA tax license and is now creating test cannabis edibles products through its Health Canada licensed research & development (R&D) lab at the group’s edibles manufacturing facility in Winnipeg, Manitoba.

The company said through its R&D license it has now dialed in formulations for cannabis activated pectin and gelatin gummies, hard candy and sugar-free variants.

READ: AgraFlora Organics expects first harvest at its Delta greenhouse in fourth quarter 2020

“As part of the R&D program, we have begun a testing project with Agilent to improve testing standards, methods, and ensure consistent quality. Our efficient and highly automated R&D production allows us to provide a variety of sample products for our prospective clients to try for their established brands,” said James Fletcher, one of the founders and the operational manager of Edibles and Infusions Corporation, a joint venture formed between AgraFlora and one of North America’s leading confectionery manufacturing families.

AgraFlora also said it submitted its site evidence package to Health Canada for a processing license on May 28, adding that it is in regular contact with the body and remains committed to the timeline of receiving the license in the fourth quarter of 2020.

Contact the author at [email protected]

Follow him on Twitter @Cal_Proac

Story by ProactiveInvestors